<?xml version="1.0" encoding="UTF-8"?>
<p>The extensive use of antimicrobials medicaments in a well-connected global human population has increased the cases of antimicrobial resistance (
 <xref rid="B104" ref-type="bibr">Michael et al., 2014</xref>). According to the UN 
 <italic>ad hoc</italic> Interagency Coordinating Group on Antimicrobial Resistance, drug-resistant diseases by 2050 can bring around 10 million deaths per year and cause an economic catastrophe similar to that of the 2008-2009 global financial recession. By 2030, antimicrobial resistance could affect approximately 24 million people plunging them into severe poverty (
 <xref rid="B181" ref-type="bibr">World Health Organisation [WHO], 2019</xref>). According to the Center for disease control and prevention, around 7% of all the blood samples from patients suffering from 
 <italic>Candida</italic> is resistant to fluconazole. However, this resistance to azole is persistent for the last 20 years, but resistance toward echinocandins and other drugs is a huge concern. Thus, this situation will prove to be lethal because of the ever -growing human population.
</p>
